Navigation Links
Relief from Menopause Symptoms Short-lived for Prempro Women Suffering from Cancers
Date:7/10/2012

CRESSKILL, N.J., July 10, 2012 /PRNewswire/ -- Prempro promised women relief from menopause symptoms, but the relief was short-lived for the estimated 10,000 plaintiffs who developed breast cancer after taking the drug. Pfizer, which purchased Prempro's original manufacturer, Wyeth, has set aside $330 million to settle 4,000 remaining suits after already settling some 6,000 suits for $896 million. The settlements come after six years of trials in which courts found Pfizer and Wyeth guilty of "wanton and reckless" behavior (http://www.drdach.com/Prempro_Dangerous.html). As it may take months, if not years, for the settlements to be disbursed, RD Legal Funding, LLC ("RD Legal") is offering the plaintiffs, and their attorneys, legal settlement funding as soon as settlement amounts have been finalized.

(Logo: http://photos.prnewswire.com/prnh/20110803/NY45278LOGO )

Prempro became the most prescribed drug in the Unites States despite conflicting studies, some claiming the drugs' health benefits and others warning of significant health risks. Prescribed originally to reduce menopausal side effects including hot flashes, Prempro is a Hormone Replacement Therapy (HRT) combining an existing Wyeth product called Premarin (conjugated equine estrogen: estrogen derived from the urine of pregnant female horses), and Provera (medroxyprogesterone acetate, a powerful synthetic progesterone).

At least 6 million women used Prempro. Sales reached $2 billion a year in 2001 before a federal study reported in 2002 that Prempro increased the incidence of breast cancer by 26 percent, heart attack by 29 percent, stroke by 41 percent, and blood clots in the legs and veins by 105 percent. A number of other adverse health consequences including ovarian and gall bladder ca
'/>"/>

SOURCE RD Legal Funding, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
3. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
4. Direct Relief Delivers Hurricane Packs As FEMA Urges Preparedness
5. MLB All-Star Pitcher CC Sabathia Issues Fast Relief Challenge to Generate Donations for the American Red Cross
6. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
7. NAMS Journal Menopause Reflects on the WHI 10 Years Later
8. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
9. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
10. Sorbent Therapeutics CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
11. Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... updated its full year 2015 financial guidance and business ... Updated Financial Guidance , Total revenues for ... expected to be between $7.0 and $8.0 million. The Company ... for the remainder of the year, and therefore expects ...
(Date:5/27/2015)... , May 27, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... a member of the Roche Group, announced today a ... for Ventana to ultimately commercialize, a companion diagnostic assay ... The Ventana assay will be used to ... – a chain of natural sugars distributed throughout human ...
(Date:5/27/2015)... 27, 2015 Encision Inc. (OTCQB:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... fiscal year ended March 31, 2015. The ... a quarterly net loss of $349 thousand, or $(0.03) ... $2.504 million for a net loss of $1.453 million, ...
Breaking Medicine Technology:IGI Laboratories Updates Business Outlook 2IGI Laboratories Updates Business Outlook 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 4Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6
... 2011 Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ... clinical and preclinical data highlighting the safety and efficacy ... New Phase 3 data on the ... after augmentation mammoplasty will be presented by Sergio Bergese, ...
... 5, 2011 Xlumena, Inc., a ... endoscopist and endoscopic surgeon, announced today that it ... AXIOS™ Stent and Delivery System (AXIOS). The AXIOS ... translumenal therapy and is indicated for drainage of ...
Cached Medicine Technology:Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations 2Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations 3Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations 4Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations 5Xlumena Receives CE Mark for Revolutionary AXIOS™ Stent and Delivery System 2
(Date:5/27/2015)... May 27, 2015 SAN DIEGO, ... Gulfport Mississippi, is the first healthcare provider along ... to chronic care management (CCM). In partnership with ... is introducing RevUp, a new program that enables ... and increase monthly reimbursements. This new, user-friendly program ...
(Date:5/27/2015)... HOUSTON, Tx (PRWEB) May 27, 2015 ... combined germline pharmacogenomic and somatic genomic analysis in personalized ... was published by the American Society of Clinical Oncology ... – June 2 in Chicago. , The molecular and ... The Cancer Genome Atlas (TCGA) database. The study reports ...
(Date:5/27/2015)... On June 5, Plan B [the agency alternative], ... to host Donate Your Break, a public blood drive. ... donor coach outside of 116 W. Illinois (at LaSalle) ... whole blood units is highest for LifeSource, the largest ... requires approximately 1,000 donations per day to maintain an ...
(Date:5/27/2015)... 2015 This is a professional ... the Omega-3 industry. The report provides a basic ... and industry chain structure. The Omega-3 market analysis ... trends, competitive landscape analysis, and key regions development ... Fishing Company, Seadragon Marine Oils, Norwegian Fish Oil, ...
(Date:5/27/2015)... 2015 SonarMD, LLC, recently ... a first-of-its kind, cloud-based algorithmic process for ... chronic gastrointestinal disease. , Developed by noted ... allows physicians to monitor their patients’ health ... of electronic health assessment surveys. Using nationally ...
Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
... Roger Seaver, president and CEO of Henry Mayo ... the Hospital Association of Southern California (HASC) for ... leading the board in developing public policies to ... and enhancing communication and consensus on public policy ...
... (UC) researchers have discovered that estrogen receptors are ... brain tumorleading them to believe that anti-estrogen drug ... and improving patients, overall outcome. , This research ... of Endocrinology . , In estrogen-responsive cancerssuch ...
... Marmot, chair of the World Health Organization Commission ... the International Institute for Society and Health at ... Health Lecture Series talk, "Social Determinants of Health: ... Lecture Series is organized by Martin Seligman, University ...
... 17 The Quantum Group, Inc. (NYSE Amex: ... PWeR(TM) (Personal Wellness electronic Record) demonstrations presented at the ... standing room only crowds throughout the 3-day event.Pete Martinez, ... Officer, led the team responsible for the development of ...
... Cross rolls out red carpet for one of its ... the most watched awards show on television, the American ... Barnes, Executive Director of the West Alabama Chapter in ... years ago in Vicksburg (MS). During his tenure with ...
... research? The National Institutes of Health (NIH) wants to ... March 4-6 on behalf of the NIH Office of ... research priorities for the next decade. The meeting begins ... health-care providers, patients, community groups, advocacy groups and other ...
Cached Medicine News:Health News:Henry Mayo CEO Elected Chairman of Hospital Association of Southern California 2Health News:Estrogen found to increase growth of the most common childhood brain tumor 2Health News:The Quantum Group Announces Standing-Room-Only PWeR(TM) Demonstrations at Pri-Med South Expo 2Health News:The Quantum Group Announces Standing-Room-Only PWeR(TM) Demonstrations at Pri-Med South Expo 3Health News:American Red Cross: Meet Our Oscar! 2Health News:American Red Cross: Meet Our Oscar! 3Health News:American Red Cross: Meet Our Oscar! 4Health News:WU hosts public hearing, conference to help NIH prioritize women's health research 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: